WIZ

Across TCGA pan-cancer cohorts, WIZ Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated WIZ data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher WIZ Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated WIZ expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

UCEC, READ, and BLCA are the cancer types where WIZ Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.825	0.631	.001	28	view →
READ	DFS	Median	All	0.269	0.819	.009	15	view →
BLCA	DFS	Median	IV	0.077	0.476	<.001	6	view →
CESC	DFS	Median	All	0.647	0.829	.044	2	view →
SKCM	DFS	Median	II,III,IV	0.909	0.681	.029	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

WIZ–UCEC (DFS)

Open the UCEC breakdown →